Should you buy, hold or sell Shine Justice shares?
Shine Justice (ASX:SHJ) is a legal services firm that is focused on seeking compensation for those who have been wronged.
Erin Brockovich, the legal researcher who was made famous when played by Julia Roberts in the film bearing her name, is an ambassador for the firm. They have traditionally focused on damages based plaintiff litigation such as for motor vehicle or workplace accidents.
Five years ago, 70% of revenue came from personal injury claims, whereas now it has fallen to 46%. In its place they have diversified into other areas, including family law, medical negligence and class actions.
During 2022 they were successful with a class action against Johnson and Johnson which took almost 10 years, relating to faulty prolapse mesh and tape implants affecting up to 12,000 Australian women. They were also successful in a number of other class actions which have become a significant source of revenue growth.
Shine's revenue has been growing steadily at about 8% per annum since they listed in 2013. Revenue growth accelerated last year to 15% resulting in total revenue of $215 million.
In most cases, Shine only receive a fee if they win the case. That means Shine carries the risk of an unfavourable outcome. They manage this through their experience as to what cases are likely to succeed and therefore they should take on. In addition, some large class actions are fully or partially funded by third parties. In these cases, the funded portion of fees is not contingent on a successful outcome.
It is important to understand how revenue and consequently profits, are recognised in Shine's books. Revenue is recognised as work is performed on a case. This means that revenue can be recognised in the accounts before the case has been resolved and well before the cash has been received.
The revenue amount is determined by making assumptions about the probable success rates. So the accuracy of the revenue figure is highly dependent on the assumptions regarding success rates.
When analysing the balance sheet there is a large asset called work in progress. In 2022 this equated to $332 million. This represents revenue that has been recognised from cases that are still in progress. The revenue has not yet been invoiced. About 55% of this revenue is expected to be realised as cash in the next 12 months with the remainder not expected for more than a year.
In 2016 Shine had to recognise a large impairment against their profits when it became apparent that their success assumptions had been too optimistic and they were not going to realise the cash revenue to match that which had been previously booked in their profit and loss statements.
Since 2016 management have applied more conservative revenue assumptions, which is evidenced by the fact that total cash flow from operations over the six year period is actually a bit higher than recorded profits. In the period prior to 2016 recorded profits were well above operating cash flow.
Monitoring cash flow and not just accounting profit is important when analysing any business, but especially so for Shine as there are large timing differences between when revenue is booked and the cash actually received, sometimes extending to many years.
Having noted the good cash flow, we can be more confident when analysing profit. Profits have fluctuated more than revenue, but earnings per share have doubled since 2016. Return on equity is a solid 12%.
Growth for Shine can come from a number of sources. One is to increase the number of fee earners in the business. Fee earners are lawyers who are able to take on cases, as opposed to support staff. This can occur through hiring or through the acquisition of existing law practices. Over the last two years, the number of fee earners has increased from 450 to 600.
Another growth source is to increase the amount of cases being pursued and also to pursue high value cases, such as some of the large class actions. To this end, Shine have marketing and media teams.
One measure of the revenue pipeline is the total cabinet of files. This is an estimate of the total fees that could be earned from cases currently being worked on. At June this stood at $630 million of which only 53% had been completed.
Market analysts are forecasting revenue growth to continue over the next two years at about 7% per annum with earnings per share growth to be slightly higher. Based on these projections, the shares are trading on a very modest forward PE ratio of 5.7.
The share price tends to trade on a low PE given the concerns around earnings transparency described above, but the current valuation is well below the five year average forward PE of 6.6. The forecast dividend yield is 6.2%. In recent years, most tax has been deferred, rather than paid, resulting in no franking credits. The fact that dividends are unfranked also contributes to the discount.
The manner of Shine's business, and therefore the way accounting standards are applied, can make it a complex business to analyse. However when you dig beneath the surface, a business that ranks highly in terms of quality and value shines through.
Get stories like this in our newsletters.